Gabelli & CO Investment Advisers, Inc. Viatris Inc Transaction History

Gabelli & CO Investment Advisers, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$9.02 - $10.29 $108,240 - $123,479	12,000 New	12,000 $119,000
Q3 2022 Nov 10, 2022	SELL	$8.48 - $11.13 $33,920 - $44,520	-4,000 Reduced 21.05%	15,000 $128,000
Q2 2022 Aug 12, 2022	BUY	$9.95 - $12.27 $4,975 - $6,135	500 Added 2.7%	19,000 $199,000
Q1 2022 May 13, 2022	SELL	$9.81 - $15.4 $14,715 - $23,100	-1,500 Reduced 7.5%	18,500 $201,000
Q4 2021 Feb 11, 2022	SELL	$12.09 - $14.68 $346,451 - $420,670	-28,656 Reduced 58.9%	20,000 $271,000
Q3 2021 Nov 12, 2021	BUY	$13.25 - $15.13 $65,759 - $75,090	4,963 Added 11.36%	48,656 $659,000
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $453,223 - $564,345	-34,944 Reduced 44.44%	43,693 $624,000
Q1 2021 May 14, 2021	BUY	$13.59 - $18.54 $176,670 - $241,020	13,000 Added 19.81%	78,637 $1.1 Million
Q4 2020 Feb 05, 2021	BUY	$14.3 - $18.74 $938,609 - $1.23 Million	65,637 New	65,637 $1.23 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Gabelli & CO Investment Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Gabelli & CO Investment Advisers, Inc. with notifications on news.